Gilead Sciences Sweden AB
- J01 - Antibacterianos para uso sistémico
- CAYSTON powder for nebuliser solution 75 mg
- J02 - Antimicóticos de uso sistémico
- AMBISOME LIPOSOMAL powder for solution for infusion 50 mg
- J05 - Antivirales de uso sistémico
- ATRIPLA film-coated tablet 600 mg+200 mg+245 mg
- BIKTARVY film-coated tablet 50 mg+200 mg+25 mg
- DESCOVY film-coated tablet 200 mg+10 mg
- DESCOVY film-coated tablet 200 mg+25 mg
- EMTRIVA capsule, hard 200 mg
- EMTRIVA oral solution 10 mg/ml
- EPCLUSA film-coated tablet 200 mg+50 mg
- EPCLUSA film-coated tablet 400 mg+100 mg
- EVIPLERA film-coated tablet 200 mg+300 mg+25 mg
- GENVOYA film-coated tablet 150 mg+150 mg+200 mg+10 mg
- HARVONI film-coated tablet 200 mg+45 mg
- HARVONI film-coated tablet 400 mg+90 mg
- HARVONI modified-release granules 150 mg+33.75 mg
- HARVONI modified-release granules 200 mg+45 mg
- HEPCLUDEX powder for solution for injection 2 mg
- HEPSERA tablet 10 mg
- ODEFSEY film-coated tablet 200 mg+25 mg+25 mg
- SOVALDI film-coated tablet 200 mg
- SOVALDI film-coated tablet 400 mg
- SOVALDI gastro-resistant granules 150 mg
- SOVALDI gastro-resistant granules 200 mg
- STRIBILD film-coated tablet 200 mg+245 mg+150 mg+150 mg
- TRUVADA film-coated tablet 200 mg+245 mg
- VEKLURY concentrate for solution for infusion 100 mg
- VEKLURY powder for solution for infusion 100 mg
- VEMLIDY film-coated tablet 25 mg
- VIREAD film-coated tablet 123 mg
- VIREAD film-coated tablet 163 mg
- VIREAD film-coated tablet 204 mg
- VIREAD film-coated tablet 245 mg
- VIREAD granules 33 mg/g
- VOSEVI film-coated tablet 400 mg+100 mg+100 mg
- L01 - Antineoplásicos
- TECARTUS dispersion 40 to 200 M.cells
- YESCARTA dispersion 40-200 M.cells
- L04 - Inmunosupresores
- JYSELECA film-coated tablet 100 mg
- JYSELECA film-coated tablet 200 mg
- V03 - Todos los demás preparados terapéuticos
- TYBOST film-coated tablet 150 mg